AdipoGen Life Sciences

FSL-1

CHF 240.00
In stock
AG-CP3-0009-C100100 µgCHF 240.00
More Information
Product Details
Synonyms Fibroblast-stimulating Lipopeptide; Pam2CGDPKHPKSF; (R,S)-Pam2Cys-Gly-Asp-Pro-Lys-His-Pro-Lys-Ser-Phe-OH
Product Type Chemical
Properties
Formula

C84H140N14O18S

MW 1666.2
CAS 322455-70-9
Source/Host Chemicals Synthetic.
Purity Chemicals Absence of detectable protein or DNA contaminants with agonistic TLR activity.
Appearance Colorless powder.
Solubility Soluble in water (10mg/ml). Use a homogeniser or sonicator to prepare a homogenous solution.
Reconstitution Reconstitute in 100μl endotoxin-free water (Prod.No. IAX-900-002) to get a 1mg/ml stock solution.
Formulation Lyophilized.
Other Product Data

Note: FSL-1 stimulation induces a MyD88-dependent signaling cascade leading to the activation of NF-κB and the production of proinflammatory cytokines. FSL-1 exhibits a higher stimulatory activity than MALP-2 when tested for its ability to induce the production of TNF-α in macrophages and NF-κB in TLR2/TLR6 transfected HEK293 cells. Depending on the sensitivity of the in vitro assay, the recommended working concentration for specific stimulation of innate immunity via TLR2/TLR6 heterodimers is 10-100nM. FSL-1 is water soluble in contrast to MALP2.

InChi Key VJJLLNHELGKSNA-YWKNMTRCSA-N
Smiles [H]C(COC(=O)CCCCCCCCCCCCCCC)(CSC[C@]([H])(N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O)OC(=O)CCCCCCCCCCCCCCC
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice After reconstitution, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description
  • FSL-1 (Pam2CGDPKHPKSF) is a synthetic lipoprotein that represents the N-terminal part of the 44kDa lipoprotein LP44 of Mycoplasma salivarium [1].
  • FSL-1 is a mixture of R,R and R,S stereoisomers
  • Stimulator of TLR2/TLR6 [2-11].
  • Inducer of TNF-α production in macrophages [4].
  • Upregulates proinflammatory cytokines [3, 4].
  • Activator of the proinflammatory transcription factor NF-κB [3].
Product References
  1. The N-terminal lipopeptide of a 44-kDa membrane-bound lipoprotein of Mycoplasma salivarium is responsible for the expression of intercellular adhesion molecule-1 on the cell surface of normal human gingival fibroblasts: K.I. Shibata, et al.; J. Immunol. 165, 6538 (2000)
  2. Discrimination of bacterial lipoproteins by Toll-like receptor 6: O. Takeuchi, et al.; Int. Immunol. 13, 933 (2001)
  3. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by Toll-Like Receptors 2 and 6: T. Okusawa, et al.; Infect. Immun. 72, 1657 (2004)
  4. Effects of repeated injections of fibroblast-stimulating lipopeptide-1 on fever, formation of cytokines, and on the responsiveness to endotoxin in guinea-pigs: A. Greis, et al.; Acta Physiol. 197, 35 (2009)
  5. Regulators of G-protein signalling are modulated by bacterial lipopeptides and lipopolysaccharide: S. Riekenberg, et al.; FEBS J. 276, 649 (2009)
  6. Toll-like receptors and innate immunity: H. Kumar, et al.; BBRC 388, 621 (2009)
  7. A new cell-based innate immune receptor assay for the examination of receptor activity, ligand specificity, signalling pathways and the detection of pyrogens: A. Burger-Kentischer, et al.; J. Immunol. Methods 358, 93 (2010)
  8. Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele: G.E. Etokebe, et al.; Scand. J. Immunol. 71, 369 (2010)
  9. TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function: M.H. Nyirenda, et al.; J. Immunol. 187, 2278 (2011)
  10. Activation of endothelial TLR2 by bacterial lipoprotein upregulates proteins specific for the neutrophil response: K. Wilhelmsen, et al.; Innate Immun. 18, 602 (2012)
  11. FcεR1-mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment: R. Saluja, et al.; PLoS One 7, e43547 (2012)
  12. Toll-like receptor ligand-dependent inflammatory responses in chick skeletal muscle myoblasts: Y. Nihashi, et al.; Dev. Comp. Immunol. 91, 115 (2019)
  13. Upregulation of PD-L1 Expression by Prostaglandin E2 and the Enhancement of IFN-γ by Anti-PD-L1 Antibody Combined With a COX-2 Inhibitor in Mycoplasma bovis Infection: S. Goto, et al.; Front. Vet. Sci. 7, 12 (2020)
  14. Hypoxia-inducible factor prolyl hydroxylase inhibitors suppressed thymic stromal lymphopoietin production and allergic responses in a mouse air-pouch-type ovalbumin sensitization model: R. Segawa, et al.; Int. Immunopharmacol. 118, 110127 (2023)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.